cilostazol has been researched along with Hepatic Veno Occlusive Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, T | 1 |
| Tajima, H | 1 |
| Hirata, M | 1 |
| Nakanuma, SI | 1 |
| Makino, I | 1 |
| Hayashi, H | 1 |
| Oyama, K | 1 |
| Miyashita, T | 1 |
| Takamura, H | 1 |
| Ninomiya, I | 1 |
| Fushida, S | 1 |
| Iseki, S | 1 |
| Harada, SI | 1 |
| Wakayama, T | 1 |
| Ohta, T | 1 |
1 other study available for cilostazol and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
Topics: Animals; Antigens, CD34; Capillaries; Cilostazol; Disease Models, Animal; Epithelial Cells; Hepatic | 2018 |